A research team in Japan has uncovered a part of the mechanism by which a substance found in Kobayashi Pharmaceutical's supplements containing red fermented rice triggered kidney damage.
https://www.japantimes.co.jp/news/2026/03/05/japan/science-health/benikoji-study/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #health #kobayashipharmaceutical #medicine
Researchers uncover mechanism behind <i>beni kōji</i> health problems
Though it had been known that puberulic acid was behind the high-profile health scare in 2024 involving supplements, it was unclear how the substance damaged kidneys.
The Japan Times
Kobayashi Pharmaceutical chairman vows corporate culture reform
Kobayashi Pharmaceutical achieved net profit growth for over 20 years from its stock market listing until the beni kо̄ji scandal emerged last year.
The Japan Times
Despite leadership changes Kobayashi Pharma still struggling with reform
The Osaka-based company has replaced its president twice and appointed an external chairman, seeking to reduce the influence of the founding family seen as a cause of the scandal.
The Japan TimesThe head of Kobayashi Pharmaceutical has promised that it will never cause health damage again, following a high-profile scare last year caused by its supplements containing red fermented rice.
https://www.japantimes.co.jp/business/2025/06/04/companies/kobayashi-health-scare/?utm_medium=Social&utm_source=mastodon #business #companies #kobayashipharmaceutical #pharmaceuticals #norikazutoyoda
Kobayashi Pharmaceutical vows never to repeat health scare
In March 2024, the drugmaker, based in Osaka, announced that it had received a series of reports about such symptoms as kidney disease from users of its supplements.
The Japan TimesIn the wake of a health scandal involving its supplements last year, Kobayashi Pharmaceutical has suffered its first year-on-year decline in group net profit since its 1999 stock listing.
https://www.japantimes.co.jp/business/2025/02/11/companies/kobayashi-pharma-profit-fall/?utm_medium=Social&utm_source=mastodon #business #companies #kobayashipharmaceutical #health #pharmaceutical
Kobayashi Pharma logs first net profit drop since 1999 listing
The company's net profit plunged 50.5% in the aftermath of a health scandal involving its supplements, which emerged last year.
The Japan Times
Hong Kong fund to sue former Kobayashi Pharma execs
The fund will seek a total of roughly ¥11 billion in damages from former Chairman Kazumasa Kobayashi and six then-board directors.
The Japan Times
Tainted beni kōji supplement linked to persistent kidney damage, study finds
The Osaka University study analyzed data from patients who reported health issues between late March and late April 2024.
The Japan TimesHong Kong-based activist investor Oasis Management has increased its equity stake in Japan's Kobayashi Pharmaceutical, rocked by a high-profile health hazard scandal over its supplements containing red fermented rice.
https://www.japantimes.co.jp/business/2024/12/26/companies/hong-kong-fund-kobayashi-pharma/?utm_medium=Social&utm_source=mastodon #business #companies #oasismanagement #kobayashipharmaceutical #investments
Hong Kong fund increases its stake in Kobayashi Pharmaceutical
Oasis Management said its stake in Kobayashi Pharmaceutical climbed to 10.1% from 7.5%.
The Japan TimesA Taiwanese consumer group sued Osaka-based Kobayashi Pharmaceutical for compensation for health issues allegedly caused by products related to its beni kōji red fermented rice on Friday, Taiwanese media reported.
https://www.japantimes.co.jp/business/2024/09/28/kobayashi-pharma-sued-taiwan/ #business #food #health #kobayashipharmaceutical #koji #taiwan #lawsuits
Kobayashi Pharma sued in Taiwan over beni kōji products
A group filed the lawsuit with the Taipei District Court against six firms including a Taiwanese unit of Kobayashi Pharmaceutical and an importer in Taiwan.
The Japan Times